Breathnach OS - Search Results

1

Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results.

Breathnach OS, Freidlin B, Conley B, Green MR, Johnson DH, Gandara DR, O'Connell M, Shepherd FA, Johnson BE. Breathnach OS, et al. J Clin Oncol. 2001 Mar 15;19(6):1734-42. doi: 10.1200/JCO.2001.19.6.1734. J Clin Oncol. 2001. PMID: 11251004

2

Lung carcinoma metastasis at the site of central venous access.

Crook JL, Breathnach OS, Cruser D, Johnson BE. Crook JL, et al. Among authors: breathnach os. Chest. 1998 Dec;114(6):1772-4. doi: 10.1378/chest.114.6.1772. Chest. 1998. PMID: 9872218

3

Cytomegalovirus pneumonia in a patient with breast cancer on chemotherapy: case report and review of the literature.

Breathnach O, Donnellan P, Collins D, McNicholas W, Crown J. Breathnach O, et al. Ann Oncol. 1999 Apr;10(4):461-5. doi: 10.1023/a:1008360927507. Ann Oncol. 1999. PMID: 10370790 Free article. Review.

4

Clinical features of patients with stage IIIB and IV bronchioloalveolar carcinoma of the lung.

Breathnach OS, Ishibe N, Williams J, Linnoila RI, Caporaso N, Johnson BE. Breathnach OS, et al. Cancer. 1999 Oct 1;86(7):1165-73. doi: 10.1002/(sici)1097-0142(19991001)86:7<1165::aid-cncr10>3.0.co;2-9. Cancer. 1999. PMID: 10506700

5

Phase II trial of paclitaxel by 96-hour continuous infusion in combination with cisplatin for patients with advanced non-small cell lung cancer.

Breathnach OS, Georgiadis MS, Schuler BS, Pizzella P, Llorens V, Kasturi V, Steinberg SM, O'Neil K, Takimoto CH, Johnson BE. Breathnach OS, et al. Clin Cancer Res. 2000 Jul;6(7):2670-6. Clin Cancer Res. 2000. PMID: 10914708 Clinical Trial.

6

Bronchioloalveolar carcinoma of the lung: recurrences and survival in patients with stage I disease.

Breathnach OS, Kwiatkowski DJ, Finkelstein DM, Godleski J, Sugarbaker DJ, Johnson BE, Mentzer S. Breathnach OS, et al. J Thorac Cardiovasc Surg. 2001 Jan;121(1):42-7. doi: 10.1067/mtc.2001.110190. J Thorac Cardiovasc Surg. 2001. PMID: 11135158 Free article.

7

Genetic changes in contralateral bronchioloalveolar carcinomas of the lung.

Shin SW, Breathnach OS, Linnoila RI, Williams J, Gillespie JW, Kelley MJ, Johnson BE. Shin SW, et al. Among authors: breathnach os. Oncology. 2001;60(1):81-7. doi: 10.1159/000055301. Oncology. 2001. PMID: 11150913

8

Phase II neoadjuvant trial of paclitaxel by 96-hour continuous infusion (CIVI) in combination with cisplatin followed by chest radiotherapy for patients with stage III non-small-cell lung cancer.

Breathnach OS, Kasturi V, Kaye F, Herscher L, Georgiadis MS, Edison M, Schuler BS, Pizzella P, Steinberg SM, O'Neil K, Johnson BE. Breathnach OS, et al. Am J Clin Oncol. 2002 Jun;25(3):269-73. doi: 10.1097/00000421-200206000-00013. Am J Clin Oncol. 2002. PMID: 12040286 Clinical Trial.

9

A model to select regimens for phase III trials for patients with advanced-stage non-small cell lung cancer.

Freidlin B, Breathnach OS, Johnson BE. Freidlin B, et al. Among authors: breathnach os. Clin Cancer Res. 2003 Mar;9(3):917-22. Clin Cancer Res. 2003. PMID: 12631588

10

Sensitivity of non-small-cell lung cancer cell lines established from patients treated with prolonged infusions of Paclitaxel.

Fujishita T, Loda M, Turner RE, Gentler M, Kashii T, Breathnach OS, Johnson BE. Fujishita T, et al. Among authors: breathnach os. Oncology. 2003;64(4):399-406. doi: 10.1159/000070299. Oncology. 2003. PMID: 12759538

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters